01/10/2023 / By Belle Carter
Pfizer’s unauthorized 1996 trial of an experimental meningitis drug on 200 Nigerian children still haunts the world 27 years on. According to analysts, the Nigeria case showed how foreign drug trials are often unregulated, dangerous and unreliable.
Investigative journalist @KanekoaTheGreat posted a Twitter thread of how Big Pharma has wronged humanity with its depopulation efforts in the guise of “curing diseases.” One tweet touched on the 1996 illegal drug trial in Nigeria’s Kano state, which was conducted without informing parents that their children were subjects of a medical experiment. Eleven children died and many others were left with serious injuries.
The parents of four Nigerian children who died in the drug trial were the first awardees of a $175,000 compensation in 2009 after more than a decade of legal battle against the drug company. The payout was issued after the parents submitted DNA samples to prove that the four casualties were indeed their children.
A June 2010 report by CBS News said the Trovan case may be related to the Food and Drug Administration‘s (FDA) investigation over lack of supervision for drug trials, which was helmed by the Office of the Inspector General under the Department of Health and Human Services.
It found that the FDA looks at only one percent of trials conducted outside the U.S., with the regulator using data from these flawed trials as a basis for approving medicines taken by Americans. It also discovered that the FDA only has two people in charge of inspecting drug factories in all of China.
Moreover, the New England Journal of Medicine warned in 2009 that foreign drug trials could cause injuries to U.S. patients because foreign test subjects may have different genetic or environmental responses to drugs. It also noted that trials overseas were plagued by ethical dilemmas as they often recruit poor, uneducated patients who lack other healthcare alternatives. (Related: Fraud, negligence and criminal acts: A closer look at Pfizer’s scandalous history.)
The scandalous drug trial in Kano left a bitter memory for many residents. It discouraged them from any and all kinds of vaccinations, including that for the Wuhan coronavirus (COVID-19).
“Since that incident of paralysis and deaths of children, I can never trust any vaccines or medicines from Europe,” Abubakar Salisu, a resident of the Gwagwarwa suburb in Kano, told Premium Times in December 2022.
He refused to get the COVID-19 injection and advised anyone against getting it. According to Salisu, some of his fellow residents think Europeans are trying to initiate Africans with the vaccines. “Our people believe the Europeans are on a mission to plant a device in our body through their vaccines,” he said.
Aliyu Musa, a resident of the Unguwa Uku neighborhood in Kano, said many parents were left with paralyzed children as a result of being administered the experimental drug Trovan without their consent.
“I’m one of those yet to take the COVID-19 vaccine and it will remain like that,” said Musa. “My family and I will not take the vaccine because we don’t trust the producers.”
A taxi driver in Kano said: “As long as it’s a vaccine or medicine from the westerners, I will not accept it. They can’t be trusted.” The taxi driver added that he feels personal anger because his family was directly affected by the Pfizer disaster.
Visit BigPharmaNews.com for more news about Pfizer’s failed drug trials.
Watch this video that discusses Pfizer paying the biggest fine for healthcare fraud in history.
This video is from the SILVIEW.media channel on Brighteon.com.
Pfizer to Pay Tens of Millions for Deaths of Nigerian Children in Drug Trial Experiment.
Sources include:
Tagged Under:
Big Pharma, corruption, covid-19, crimes against humanity, experimental drugs, guinea pigs, human rights abuses, medical experiments, meningitis, Nigeria, Pfizer, pharmaceutical fraud, science deception, science fraud, Trovan, unauthorized trial, vaccine
This article may contain statements that reflect the opinion of the author
COPYRIGHT © 2017 BIG PHARMA NEWS